{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:05:33Z","timestamp":1784156733505,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Key Research and Development Program of China","award":["1308304"],"award-info":[{"award-number":["1308304"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670367"],"award-info":[{"award-number":["81670367"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Planning Project Foundation of Guangzhou","award":["201707020012"],"award-info":[{"award-number":["201707020012"]}]}],"content-domain":{"domain":["nmcd-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.numecd.2019.01.001","type":"journal-article","created":{"date-parts":[[2019,1,12]],"date-time":"2019-01-12T02:23:12Z","timestamp":1547259792000},"page":"351-359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Association of serum uric acid change with mortality, renal function and diuretic dose administered in treatment of acute heart failure"],"prefix":"10.1016","volume":"29","author":[{"given":"H.-B.","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.-Y.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-R.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-J.","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.-F.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.-C.","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.-L.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2019.01.001_bib1","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00467-013-2549-x","article-title":"Uric acid and the kidney","volume":"29","author":"Fathallah-Shaykh","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.numecd.2019.01.001_bib2","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/oxfordjournals.eurheartj.a015352","article-title":"Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure","volume":"18","author":"Leyva","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2019.01.001_bib3","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1053\/euhj.1998.1188","article-title":"Uric acid in chronic heart failure: a marker of chronic inflammation","volume":"19","author":"Leyva","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2019.01.001_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/hrt.78.1.39","article-title":"Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure","volume":"78","author":"Anker","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.numecd.2019.01.001_bib5","first-page":"25","article-title":"Hyperuricemia and insulin resistance","volume":"78","author":"Vuorinen-Markkola","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2019.01.001_bib6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1471-2369-14-164","article-title":"The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality","volume":"14","author":"Gustafsson","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.numecd.2019.01.001_bib7","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.amjcard.2017.06.057","article-title":"Prevalence of hyperuricemia in patients with acute heart failure with either reduced or preserved ejection fraction","volume":"120","author":"Palazzuoli","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2019.01.001_bib8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ejheart.2006.09.001","article-title":"Hyperuricaemia and long-term outcome after hospital discharge in acute heart failure patients","volume":"9","author":"Pascual-Figal","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.numecd.2019.01.001_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijcard.2010.05.002","article-title":"Hyperuricemia predicts adverse outcomes in patients with heart failure","volume":"151","author":"Hamaguchi","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.numecd.2019.01.001_bib10","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.amjcard.2016.02.039","article-title":"Prognostic significance of hyperuricemia in patients with acute heart failure","volume":"117","author":"Palazzuoli","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2019.01.001_bib11","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/eurheartj\/ehq473","article-title":"Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data","volume":"32","author":"Filippatos","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2019.01.001_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.metabol.2018.02.007","article-title":"Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: a post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial","volume":"83","author":"Mantovani","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.numecd.2019.01.001_bib13","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1161\/CIRCULATIONAHA.106.651117","article-title":"High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid","volume":"114","author":"George","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2019.01.001_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCHEARTFAILURE.109.868604","article-title":"Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study","volume":"3","author":"Ogino","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.numecd.2019.01.001_bib15","first-page":"195","article-title":"Editorial Board of Chinese Journal of Cardiology. Guideline for diagnosis and treatment of acute heart failure","volume":"38","author":"Chinese Society of Cardiology of Chinese Medical Association","year":"2010","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.numecd.2019.01.001_bib16","first-page":"98","article-title":"Editorial Board of Chinese Journal of Cardiology. Chinese guidelines for the diagnosis and treatment of heart failure 2014","volume":"42","author":"Chinese Society of Cardiology of Chinese Medical Association","year":"2014","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.numecd.2019.01.001_bib17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2019.01.001_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003109","article-title":"Hypochloremia, diuretic resistance, and outcome in patients with acute heart failure","volume":"9","author":"Ter Maaten","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.numecd.2019.01.001_bib19","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cardfail.2012.06.528","article-title":"Changes in uric acid levels and allopurinol use in chronic heart failure: association with improved survival","volume":"18","author":"Gotsman","year":"2012","journal-title":"J Card Fail"},{"key":"10.1016\/j.numecd.2019.01.001_bib20","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1253\/circj.CJ-15-0964","article-title":"Determinants and prognostic impact of hyperuricemia in hospitalization for acute heart failure","volume":"80","author":"Huang","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.numecd.2019.01.001_bib21","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.amjcard.2014.09.008","article-title":"Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan trial)","volume":"114","author":"Vaduganathan","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2019.01.001_bib22","doi-asserted-by":"crossref","first-page":"762820","DOI":"10.1155\/2015\/762820","article-title":"Prevalence of hyperuricemia and gout in Mainland China from 2000 to 2014: a systematic review and meta-analysis","volume":"2015","author":"Liu","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.numecd.2019.01.001_bib23","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ejheart.2004.09.018","article-title":"Uric acid renal excretion and renal insufficiency in decompensated severe heart failure","volume":"7","author":"Ochiai","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.numecd.2019.01.001_bib24","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1161\/01.CIR.0000041431.57222.AF","article-title":"Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase","volume":"106","author":"Landmesser","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2019.01.001_bib25","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/01.CIR.0000065637.10517.A0","article-title":"Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging","volume":"107","author":"Anker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2019.01.001_bib26","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/hc4501.098928","article-title":"Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy","volume":"104","author":"Cappola","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2019.01.001_bib27","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.cardfail.2007.11.001","article-title":"Xanthine oxidase inhibition improves left ventricular dysfunction in dilated cardiomyopathic hamsters","volume":"14","author":"Hayashi","year":"2008","journal-title":"J Card Fail"},{"key":"10.1016\/j.numecd.2019.01.001_bib28","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/hrt.2004.040477","article-title":"Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure","volume":"91","author":"Gavin","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.numecd.2019.01.001_bib29","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.healun.2010.10.003","article-title":"Xanthine-oxidase inhibitors and statins in chronic heart failure: effects on vascular and functional parameters","volume":"30","author":"Greig","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.numecd.2019.01.001_bib30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4103\/0975-3583.74262","article-title":"Allopurinol and global left myocardial function in heart failure patients","volume":"1","author":"Nasr","year":"2010","journal-title":"J Cardiovasc Dis Res"},{"key":"10.1016\/j.numecd.2019.01.001_bib31","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.jacc.2008.01.068","article-title":"Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study","volume":"51","author":"Hare","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2019.01.001_bib32","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.114.014536","article-title":"Effects of xanthine oxidase inhibition in hyperuricemic heart failure patients: the xanthine oxidase inhibition for hyperuricemic heart failure patients (EXACT-HF) study","volume":"131","author":"Givertz","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2019.01.001_bib33","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1080\/03007995.2016.1218840","article-title":"Hyperuricemia, the kidneys, and the spectrum of associated diseases: a narrative review","volume":"32","author":"Jalal","year":"2016","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.numecd.2019.01.001_bib34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/MNH.0b013e32835ddad2","article-title":"The kidney in hyperuricemia and gout","volume":"22","author":"Mount","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.numecd.2019.01.001_bib35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCULATIONAHA.109.933275","article-title":"Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival","volume":"122","author":"Testani","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2019.01.001_bib36","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1161\/CIRCHEARTFAILURE.111.963256","article-title":"Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction","volume":"4","author":"Testani","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.numecd.2019.01.001_bib37","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/2048872612457044","article-title":"Treating volume overload in acutely decompensated heart failure: established and novel therapeutic approaches","volume":"1","author":"Koniari","year":"2012","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.numecd.2019.01.001_bib38","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","article-title":"Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?","volume":"41","author":"Johnson","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2019.01.001_bib39","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/bmj.300.6730.975","article-title":"Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects","volume":"300","author":"Carlsen","year":"1990","journal-title":"BMJ"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475319300031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475319300031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T22:39:53Z","timestamp":1565217593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475319300031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0939475319300031"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2019.01.001","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of serum uric acid change with mortality, renal function and diuretic dose administered in treatment of acute heart failure","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2019.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V. on behalf of The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University.","name":"copyright","label":"Copyright"}]}}